Name: Emerging Nanomedicines for Diabetes Mellitus Theranostics (Micro and Nano Technologies) (en Inglés)
Price: 142530.00 CLP
Availability: InStock
Author: Michael K Danquah; Jaison Jeevanandam
ISBN: 9780323853897

portada Emerging Nanomedicines for Diabetes Mellitus Theranostics (Micro and Nano Technologies) (en Inglés)

Formato

Libro Físico

Editorial

Elsevier

Autor

Michael K Danquah; Jaison Jeevanandam

Idioma

Inglés

N° páginas

280

Encuadernación

Tapa Blanda

ISBN13

9780323853897

N° edición

Emerging Nanomedicines for Diabetes Mellitus Theranostics (Micro and Nano Technologies) (en Inglés)

Michael K Danquah; Jaison Jeevanandam (Autor) · Elsevier · Tapa Blanda

Libro Nuevo

$ 142.530

$ 285.050

Ahorras: $ 142.520

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 03 de Julio y el Lunes 15 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Emerging Nanomedicines for Diabetes Mellitus Theranostics (Micro and Nano Technologies) (en Inglés)"

Emerging Nanomedicines for Diabetes Mellitus Theranostics provides readers with information on the development of efficacious nanomedicines as potential theranostic agents for diabetes. The book discusses the application of various novel nanomaterials and nanocomposites for targeted delivery of insulin, glucose sensing, including nano-tattoos as glucose monitors, biosynthesized nanoparticles for diabetes treatment, and pre-clinical and clinical assays to evaluate the efficacy of nanomedicines for diabetes treatment. This is an important references source for materials scientists, pharmaceutical scientists and biomedical engineers who want to increase their understanding of how nanotechnology is being used to improve diabetes treatment. Diabetes has emerged as one of the most common diseases associated with lifestyle choices in the modern world, with significant mortality rates. Conventional treatment methods mainly involve insulin-based therapies. However, insulin therapy possesses several limitations such as weight gain and hypoglycemia. Thus, advanced research in nanomedicine is targeting the development of new and improved diagnostics and treatment methods for diabetes.